Development of PRS-400, an inhaled Jagged-1 Anticalin protein for the treatment of muco-obstructive lung diseases

Autor: M Hagner, C Wurzenberger, J Peper-Gabriel, D Jaquin, N Quilitz, C Hechinger, T Jaquin, K Heinig, E Hansbauer, S Grüner, J Prassler, R S Bel Aiba, J Mayer, R Bharti, J A Wrennall, R Tarran, A Ray, S Wenzel, C Rothe, S A Olwill, G Matschiner, A Fysikopoulos
Rok vydání: 2022
Zdroj: 03.02 - Airway cell biology and immunopathology.
DOI: 10.1183/13993003.congress-2022.931
Databáze: OpenAIRE